Estrogen Hormone Protocol

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 1995

Primary Completion Date

January 31, 1999

Study Completion Date

January 31, 1999

Conditions
Alzheimer Disease
Interventions
DRUG

Estrogen

Trial Locations (25)

10016

New York University Medical Center, New York

10029

Mount Sinai School of Medicine, New York

10605

Burke Medical Research Institute, White Plains

11032

Columbia Presbyterian Medical Center, New York

15213

University of Pittsburgh, Pittsburgh

19104

University of Pennsylvania, Philadelphia

21224

Johns Hopkins University, Baltimore

30329

Emory University, Atlanta

32225

Mayo Clinic Jacksonville, Jacksonville

44120

University Hospitals of Cleveland, Cleveland

55455

University of Minnesota, Minneapolis

60612

Rush Presbyterian St. Luke's Medical Center, Chicago

62702

Southern Illinois University, Springfield

63110

Washington University, St Louis

66160

University of Kansas Medical Center, Kansas City

75235

University of Texas, Dallas

77030

Baylor College of Medicine, Houston

92093

University of California, San Diego, San Diego

98195

University of Washington, Seattle

35294-0017

University of Alabama, Birmingham, Birmingham

Unknown

University of South Florida, Tampa

46202-5266

Indiana University Medical Center, Indianapolis

40536-0230

University of Kentucky, Lexington

02114

Massachusetts General Hospital, Boston

55901-0144

Mayo Clinic, Rochester

All Listed Sponsors
lead

National Institute on Aging (NIA)

NIH

NCT00000177 - Estrogen Hormone Protocol | Biotech Hunter | Biotech Hunter